ClinicalTrials.Veeva

Menu

Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease (NAFLDDMCKD)

U

University of Pecs

Status

Unknown

Conditions

Chronic Kidney Disease
Diabetes Mellitus
Non-alcoholic Fatty Liver Disease

Treatments

Other: non-interventional study

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02947568
Pecs_NAFLD_01

Details and patient eligibility

About

The present study investigates relationship between non-alcoholic fatty liver disease and its risk factors, such as genetic background and diseases, such as chronic kidney disease and diabetes mellitus.

Full description

Non-alcoholic fatty liver disease (NAFLD) is a multisystemic disease, also affecting extrahepatic organs (1,2,6). According to former data, not only the prevalence of chronic hepatic disease, chronic cardiovascular diseases, but also the prevalence of chronic kidney disease (CKD) is higher in NAFLD (4,7). A strong association has been shown between diabetes mellitus (DM) and NAFLD as well (3,5,10).

Many genetical factors have been studied in the background of NAFLD. Many studies have proved the effect of patatin-like phospholipase domain-containing protein 3 gene (PNPLA3) (8,9). Effect of numerous genetical polymorphisms has been suggested behind oxidative stress responsible for NAFLD (8).

Enrollment

600 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CKD (renal replacement therapy non excluded)
  • DM
  • CKD+DM

Exclusion criteria

  • alcohol abuse

Trial design

600 participants in 3 patient groups

CKD
Description:
chronic kidney disease
Treatment:
Other: non-interventional study
DM
Description:
diabetes mellitus
Treatment:
Other: non-interventional study
CKD+DM
Description:
chronic kidney disease + diabetes mellitus
Treatment:
Other: non-interventional study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems